Effectiveness of lentivirus-mediated RNA interference targeting mouse tumor necrosis factor α in vitro and in vivo

  • Authors:
    • Jibo Wang
    • Yingjie Zhao
    • Miaomiao Xin
    • Lin Pan
    • Liqin Wang
    • Kun Yang
  • View Affiliations

  • Published online on: December 11, 2017     https://doi.org/10.3892/etm.2017.5609
  • Pages:2134-2139
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The aim of the present study was to identify the effectiveness of lentivirus‑mediated RNA interference (RNAi) targeting mouse tumor necrosis factor‑α (TNF‑α). RNAi lentivirus was used in vitro to transfect RAW264.7 cells, and the expression of TNF‑α, interleukin (IL)‑1β and IL‑6 mRNAs and TNF‑α protein in RAW264.7 cells was measured by reverse transcription quantitative polymerase chain reaction (RT‑qPCR) and enzyme‑linked immunosorbent assay, respectively. In vivo, mice with collagen‑induced arthritis (CIA) were injected intravenously with RNAi lentivirus, and CIA arthritis scores and the serum levels of TNF‑α were detected. Additionally, joint tissues were subjected to pathological examination. In the cells, the expression level of TNF‑α mRNA in the RNAi lentivirus group was 0.29±0.02, which was significantly lower than that of the lentivirus negative control (0.93±0.01; t=25.4, P<0.001). In the mice, the serum TNF‑α level in the RNAi lentivirus group was 249.25±11.22 ng/ml, which was significantly lower than that of the negative control group (381.86±6.28 ng/ml; P<0.05). However, no difference in IL‑1α and IL‑6 mRNA levels was identified among the groups (t=1.00, P=0.37; t=1.22, P=0.29). The CIA arthritis score in the RNAi lentivirus group was significantly reduced compared with those in the control and negative control groups (P<0.05). Furthermore, the arthritis scores in the RNAi lentivirus and positive control groups continued to decrease for ≥2 weeks, and the serum TNF‑α levels in the RNAi lentivirus and positive control groups were 31.58±2.18 and 35.21±2.25 pg/ml, which were significantly lower than those in the negative control group (46.62±3.02 pg/ml; P<0.05). Thus, targeting of the TNF‑α gene in mice via lentivirus-mediated RNAi in vitro and in vivo achieved TNF‑α gene downregulation, which indicates that lentivirus‑mediated RNA interference may be an effective form of gene therapy against rheumatoid arthritis.

Related Articles

Journal Cover

February 2018
Volume 15 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

2016 Impact Factor: 1.261
Ranked #50/128 Medicine Research and Experimental
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, J., Zhao, Y., Xin, M., Pan, L., Wang, L., & Yang, K. (2018). Effectiveness of lentivirus-mediated RNA interference targeting mouse tumor necrosis factor α in vitro and in vivo. Experimental and Therapeutic Medicine, 15, 2134-2139. https://doi.org/10.3892/etm.2017.5609
MLA
Wang, J., Zhao, Y., Xin, M., Pan, L., Wang, L., Yang, K."Effectiveness of lentivirus-mediated RNA interference targeting mouse tumor necrosis factor α in vitro and in vivo". Experimental and Therapeutic Medicine 15.2 (2018): 2134-2139.
Chicago
Wang, J., Zhao, Y., Xin, M., Pan, L., Wang, L., Yang, K."Effectiveness of lentivirus-mediated RNA interference targeting mouse tumor necrosis factor α in vitro and in vivo". Experimental and Therapeutic Medicine 15, no. 2 (2018): 2134-2139. https://doi.org/10.3892/etm.2017.5609